Event Sponsors:
The Israeli Association for the Study of Diabetes (IASD)
|
What would you like to see?
Scientific program |
Posters exhibition |
Important deadline |
Local Organizing Committee (Loc) |
Scientific Committee |
Registration |
Sponsors |
Conference secretariat |
Map
Scientific program
The journal of Human Gene Therapy is the official journal of the Israeli Society of Gene and Cell Therapy. The conference's abstracts will be published on the May 20, 2009, issue.
Abstracts are already published on the journal's website. To view them, click the link below. They appear under Fast Track Articles, devided into 3 sections: Oral presentations, Poster presentations and Author Index.
To view Conference's Abstracts online, please visit the journal of Human Gene Therapy's website: www.liebertonline.com/hum.
To download the scientific program click here
| 8:00 – 8:50 |
REGISTRATION AND POSTER ASSEMBLY
|
| 8:50 – 9:00 |
OPENING AND GREETINGS:
Angel Porgador - Conference Chairman
Shaul Sofer- Dean, Faculty of Health Sciences, Ben Gurion University, Israel
|
| SESSION 1 |
MicroRNA/SiRNA-BASED GENE THERAPY
Chairpersons – Zvi Bentwich, Sarah Ferber
|
|
9:00 – 9:30
|
KEYNOTE LECTURE 1
SMALL RNA-BASED GENE THERAPY FOR THE TREATMENT OF HIV-1 INFECTION
John J Rossi, Beckman Research Institute of the City of Hope, Duarte, CA, USA
|
| 9:30 – 9:50 |
IMMUNE TARGETING NANOPARTICLES CONTAINING SIRNAS TO CURTAIL LEUKOCYTE-IMPLICATED DISEASES
Dan Peer, Tel Aviv University, Tel Aviv, Israel
|
| 9:50 – 10:10 |
THE NON-CODING ONCOFETAL H19 RNA - A NEW DRUG FOR CANCER TREATMENT
Avraham Hochberg, Hebrew University, Jerusalem, Israel
|
| 10:10 – 10:30 |
REGULATING THE REGULATORS: TRANSCRIPTIONAL CONTROL OF miRNA GENE EXPRESSION
Michael D Walker, T Avnit-Sagi, L Kantorovich, S Kredo-Russo, E Hornstein, Weizmann Institute of Science, Rehovot, Israel
|
| 10:30 – 10:50 |
CELL DELIVERED GENE THERAPY FOR HIV
Geoff Symonds, Calimmune Inc St Vincent's Centre for Applied Medical Research, Darlinghurst , Australia
|
| 10:50 – 11:05 |
HUMAN HERPES SIMPLEX VIRUS 2 (HSV2) ENCODED MicroRNAs - HIGH CONSERVATION WITH HSV1 AND CENTRAL ROLE IN LATENCY CONTROL
Zvi Bentwich, Y Shemer Avni, N Aizenberg, I Reichenstein, A Levi, E Meiri, Ben-Gurion University, Beer Sheva, Israel
|
| 11:05 – 11:25 |
COFFEE BREAK
|
| SESSION 2 |
TISSUE AND CELL THERAPY
Chairperson – Michael Walker, Smadar Cohen
|
| 11:25 – 11:55 |
KEYNOTE LECTURE 2
ENGINEERING T CELLS FOR ADOPTIVE THERAPY
Carl June, C Carpenito, M Milone, R Carroll, J Riley, University of Pennsylvania, USA
|
| 11:55 – 12:15 |
REPROGRAMMING THE ANTI-TUMOR T-LYMPHOCYTE RESPONSE
Cyrille J Cohen, A Friedman, G Bialer, I Daniel-Meshulam, M Fried, Bar-Ilan University, Ramat Gan, Israel
|
| 12:15 – 12:35 |
PHASE I/II CLINICAL TRIAL IN ADVANCED METASTATIC CANCER
Dror Harats, Vascular Biogenics Ltd., Or Yehuda, Israel
|
| 12:35 – 12:55 |
GENE-ACTIVATED VASCULAR CELLS FOR INDUCTION OF ARTERIOGENESIS
Moshe Y Flugelman, Technion-IIT and MGVS Ltd., Haifa, Israel
|
| 12:55 – 13:10 |
GENE TARGETING VIA HOMING ENDONUCLEASES
Adi Barzel, E Privman, E Shachar, H Giladi, M Pe'eri, M Hamami, D Burstein, E Galun, T Pupko, M Kupiec, Tel Aviv University, Tel Aviv, Israel
|
| 13:10 – 13:25 |
TRANSDIFFERENTIATION OF NORMAL HUMAN NEONATE FIBROBLASTS TO PRODUCE CARTILAGE AND BONE TISSUES IN 3D CULTURES
Raphael Gorodetsky, E Gaberman, L Levdansky, Hadassah Medical Organization, Jerusalem, Israel
|
| 13:25 – 14:30 |
POSTER SESSION & LUNCH
|
| SESSION 3 |
VIRAL-BASED GENE THERAPY; EMERGING TECHNOLOGIES
Chairpersons – Yaakov Pollack, Eithan Galun
|
| 14:30 – 14:50 |
EFFECTS OF HERPES SIMPLEX VIRUS THYMIDINE KINASE GENE TRANSDUCTION ON TUMOR CELL BIOLOGY
Riad Agbaria, A Konson , JA Mahajna , G Rimon, Ben-Gurion University, Beer-Sheva, Israel
|
| 14:50 – 15:10 |
AN AUTOLOGUS TRANSDUCED BIOPUMP WITH AN ADENO-GUTLESS EPO VECTOR FOR THE TREATMENT OF ANEMIA IN CHRONIC RENAL FAILURE PATIENTS
Michal Dranitzki Elhalel, L Dotan A Pearlman, B Stern, P Ng, E Shoshani, S McMurray, AR Nissenson, E Galun, Hadassah Medical Organization, Jerusalem, Israel
|
| 15:10 – 15:30 |
LENTIVIRUS DISPLAY: STABLE EXPRESSION OF HUMAN ANTIBODIES ON THE SURFACE OF HUMAN CELLS AND VIRUS PARTICLES
Ran Taube, Q Zhu, WA Marasco, Ben Gurion University, Israel
|
| 15:30 – 16:00 |
KEYNOTE LECTURE 3
TARGETING GENE TRANSFER TO IMPROVE THE EFFICACY AND SAFETY OF GENE THERAPY
Luigi Naldini, B Gentner, A Giustacchini, I Visigalli, G Schira , A Biffi, HSR-TIGET & Vita Salute San Raffaele University, Milan, Italy
|
| 16:00 – 16:15 |
SUCCESSFUL NEONATAL GENE THERAPY OF GLYCOGEN STORAGE DISEASE TYPE IA USING A FELINE IMMUNODEFICIENCY VIRUS BASED VECTOR
Albert Grinshpun, R Condiotti, E Zeig, M Pe'er, SN Waddington, JY Chou, E Galun, Hadassah Medical Organization, Jerusalem, Israel
|
| 16:15 – 16:30 |
ONCOLYTIC HERPES SIMPLEX VIRUS-1 (HSV-1) MUTANTS AS POTENTIAL VECTORS FOR CANCER GENE THERAPY
Pnina Schlesinger, E Noach, N Rivkin, N Frenkel, Tel Aviv University, Tel Aviv, Israel
|
| 16:30 – 17:00 |
CONFERENCE CLOSURE – COCKTAIL
|
|
